» Articles » PMID: 30544452

Gender Specific Effect of CETP Rs708272 Polymorphism on Lipid and Atherogenic Index of Plasma Levels but Not on the Risk of Coronary Artery Disease: A Case-control Study

Overview
Specialty General Medicine
Date 2018 Dec 15
PMID 30544452
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies have shown a relationship between cholesteryl ester transfer protein (CETP) polymorphism in the synthesis of high-density lipoprotein cholesterol (HDL-C) and the coronary artery disease (CAD) susceptibility, but the results have remained inconsistent. In addition, there was no study exploring the relationship between CETP polymorphisms and atherogenic index of plasma (AIP) levels.We conducted a case-control study to evaluate the relationship between CETP rs708272 polymorphism and CAD risk and lipid levels in Chinese Han population. 556 CAD patients and 414 controls undergoing coronary angiography were consecutively enrolled in the hospital-based study. Polymerase chain reaction-ligase detection reaction (PCR-LDR) method was used to detect the different genotypes at rs708272.No significant association between CETP rs708272 polymorphism and CAD risk was observed in different genetic models. In the whole population, participants with TT genotype had higher HDL-C levels (1.17 ± 0.31 mmol/L vs 1.09 ± 0.29 mmol/L, P = .001) and lower AIP levels (0.08 ± 0.35 vs 0.16 ± 0.31, P = .004) compared to those with CC genotype, after adjusting for age, gender, smoking, essential hypertension (EH), and DM. The T allele carriers had higher HDL-C levels than the T allele non-carriers (1.13 ± 0.29 mmol/L vs 1.09 ± 0.29 mmol/L, P = .023). Furthermore, subgroup analyses based on gender were carried out. In males, the results showed that participants with TT genotype had significant higher HDL-C levels and lower AIP levels compared with CC genotype (P <.05). In addition, males with CT+TT genotypes had higher HDL-C levels and lower AIP levels than those with CC genotypes (HDL-C: CT+TT 1.11 ± 0.31vs CC 1.06 ± 0.30 mmol/L, P = .041; AIP: CT+TT 0.12 ± 0.32vs CC 0.16 ± 0.31, P = .034, respectively). However, there were no significant associations between lipid levels and CETP rs708272 polymorphism in females, after adjusting for confounders.CETP rs708272 polymorphism has a gender-specific effect on lipid and AIP levels but not on the risk of CAD.

Citing Articles

The link between the atherogenic index of plasma and the risk of hypertension: Analysis from NHANES 2017-2020.

Liu K, Ji Q, Qin S, Liu L, Zhang H, Huang H PLoS One. 2025; 20(1):e0317116.

PMID: 39869615 PMC: 11771876. DOI: 10.1371/journal.pone.0317116.


Association of the ESR1 (rs9340799), OLR1 (rs3736234), LIPC (rs2070895), VDR (rs2228570), and CETP (rs708272) Polymorphisms With Risk of Coronary Artery Disease in Iranian Patients.

Miri Karam Z, Yari A, Najmadini A, Khorasani N, Attari R, Jafarinejad-Farsangi S J Clin Lab Anal. 2024; 38(6):e25026.

PMID: 38506378 PMC: 10997818. DOI: 10.1002/jcla.25026.


Cholesteryl Ester Transfer Protein (CETP) Variations in Relation to Lipid Profiles and Cardiovascular Diseases: An Update.

Dabravolski S, Orekhov N, Melnichenko A, Sukhorukov V, Popov M, Orekhov A Curr Pharm Des. 2024; 30(10):742-756.

PMID: 38425105 DOI: 10.2174/0113816128284695240219093612.


Association of the polymorphisms of the cholesteryl ester transfer protein gene with coronary artery disease: a meta-analysis.

Zhang R, Xie Q, Xiao P Front Cardiovasc Med. 2023; 10:1260679.

PMID: 38146445 PMC: 10749314. DOI: 10.3389/fcvm.2023.1260679.


Interaction between CETP Taq1B polymorphism and dietary patterns on lipid profile and severity of coronary arteries stenosis in patients under coronary angiography: a cross-sectional study.

AhmadiVasmehjani A, Seyedhosseini S, Khayyatzadeh S, Madadizadeh F, Mazaheri-Naeini M, Yavari M Nutr J. 2023; 22(1):70.

PMID: 38098040 PMC: 10720056. DOI: 10.1186/s12937-023-00899-w.


References
1.
Masson W, Lobo M, Siniawski D, Huerin M, Molinero G, Valero R . Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk. Diabetes Metab. 2018; 44(6):508-513. DOI: 10.1016/j.diabet.2018.02.005. View

2.
Silbernagel G, Pagel P, Pfahlert V, Genser B, Scharnagl H, Kleber M . High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality. Clin Chem. 2017; 63(12):1886-1896. DOI: 10.1373/clinchem.2017.275636. View

3.
Abdel Maksoud S, El-Garf W, Ali O, Shaaban G, Amer N . Association of Cholesterol Ester Transfer Protein Taq IB Polymorphism With Acute Coronary Syndrome in Egyptian National Patients. Lab Med. 2017; 48(2):154-165. DOI: 10.1093/labmed/lmw071. View

4.
Cai G, Shi G, Xue S, Lu W . The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore). 2017; 96(37):e8058. PMC: 5604669. DOI: 10.1097/MD.0000000000008058. View

5.
Boden W, Probstfield J, Anderson T, Chaitman B, Desvignes-Nickens P, Koprowicz K . Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011; 365(24):2255-67. DOI: 10.1056/NEJMoa1107579. View